RBC Capital Downgrades Agios Pharma (AGIO) to Sector Perform Nov 19, 2025 12:44PM
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 May 9, 2025 07:00AM
Biotech sector Q1 earnings preview from RBC Capital Markets Apr 12, 2025 04:00AM
RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA Jan 13, 2025 12:50PM
Agios Pharma (AGIO) PT Raised to $57 at RBC Capital; 'We Are Continued Buyers' Dec 10, 2024 07:28AM


Aug 2, 2024 06:21AM Agios Pharma (AGIO) PT Raised to $55 at RBC Capital
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
May 3, 2024 07:00AM Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
May 3, 2024 06:34AM Agios Pharma (AGIO) PT Raised to $44 at RBC Capital
Apr 25, 2023 07:00AM Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023
May 10, 2022 07:00AM Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 17, 2022
May 12, 2020 07:00AM Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020
Oct 1, 2019 06:56AM Agios Pharma (AGIO) PT Lowered to $82 at RBC Capital
Aug 2, 2019 06:38AM Agios Pharma (AGIO) PT Lowered to $89 at RBC Capital
May 16, 2019 06:27AM Agios Pharma (AGIO) PT Raised to $90 at RBC Capital
Jun 4, 2018 01:47PM RBC Tells Clients to Buy Agios Pharma (AGIO) on Weakness
May 7, 2018 07:39AM Agios Pharma (AGIO) PT Raised to $90 at RBC Capital
Jan 23, 2018 04:01PM Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
Jan 19, 2018 05:48AM Agios Pharma (AGIO) Prices 7.1M Share Common Offering at $67/Sh
Jan 18, 2018 08:43PM Agios Announces Pricing of $475 Million Public Offering of Common Stock
Sep 14, 2017 04:27PM RBC Capital Starts Agios Pharma (AGIO) at Outperform
Aug 19, 2013 10:29AM Notable Analyst Rating Changes 08/19: (INTC) (HUN) (DG) Upgraded; (FMD) (HK) (TRLA) Downgraded